SEOM clinical guidelines in early stage breast cancer (2018)

被引：53

作者：

Ayala de la Pena, F. ^{[1
]}

Andres, R. ^{[2
]}

Garcia-Saenz, J. A. ^{[3
]}

Manso, L. ^{[4
]}

Margeli, M. ^{[5
]}

Dalmau, E. ^{[6
]}

Pernas, S. ^{[7
]}

Prat, A. ^{[8
]}

Servitja, S. ^{[9
]}

Ciruelos, E. ^{[10
,11
]}

机构：

[1] Hosp G Univ Morales Meseguer, Dept Hematol & Med Oncol, Avda Marques Velez S-N, Murcia 30001, Spain

[2] Hosp Clin Univ Lozano Blesa, Div Med Oncol, Zaragoza, Spain

[3] Hosp Clin Univ San Carlos, Dept Med Oncol, Madrid, Spain

[4] Univ Hosp, Dept Med Oncol, 12 Octubre, Madrid, Spain

[5] Inst Catala Oncol, Dept Med Oncol, Breast Canc Unit, BARGO Grp, Badalona, Spain

[6] Univ Hosp, Dept Oncol, Parc Tauli Sabadell, Barcelona, Spain

[7] Inst Catala Oncol, Dept Med Oncol, Breast Canc Unit, Barcelona, Spain

[8] Hosp Clin Barcelona, Dept Med Oncol, Barcelona, Spain

[9] Hosp del Mar, Dept Med Oncol, Barcelona, Spain

[10] Univ Hosp, Dept Med Oncol, Breast Canc Unit, 12 Octubre, Madrid, Spain

[11] HM Hosp, Madrid, Spain

来源：

CLINICAL & TRANSLATIONAL ONCOLOGY | 2019年 / 21卷 / 01期

关键词：

Early breast cancer; Adjuvant; Neoadjuvant; Genomic predictive test; Follow-up; 21-GENE RECURRENCE SCORE; NEOADJUVANT CHEMOTHERAPY; POSTMENOPAUSAL WOMEN; ADJUVANT TAMOXIFEN; DISTANT RECURRENCE; FOLLOW-UP; PAM50; RISK; OPEN-LABEL; PROGNOSTIC-FACTORS; RADIATION-THERAPY;

D O I：

10.1007/s12094-018-1973-6

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Breast cancer is the most common cancer in women in our country and it is usually diagnosed in the early and potentially curable stages. Nevertheless, around 20-30% of patients will relapse despite appropriate locoregional and systemic therapies. A better knowledge of this disease is improving our ability to select the most appropriate therapy for each patient with a recent diagnosis of an early stage breast cancer, minimizing unnecessary toxicities and improving long-term efficacy.

引用

页码：18 / 30

页数：13

共 90 条

[1]

Abe O, 2005, LANCET, V365, P1687, DOI 10.1016/s0140-6736(05)66544-0

[2] Chemotherapy (CT) and hormonotherapy (HT) as neoadjuvant treatment in luminal breast cancer patients: results from the GEICAM/2006-03, a multicenter, randomized, phase-II study [J].

Alba, E. ;

Calvo, L. ;

Albanell, J. ;

De la Haba, J. R. ;

Arcusa Lanza, A. ;

Chacon, J. I. ;

Sanchez-Rovira, P. ;

Plazaola, A. ;

Lopez Garcia-Asenjo, J. A. ;

Bermejo, B. ;

Carrasco, E. ;

Lluch, A. .

ANNALS OF ONCOLOGY, 2012, 23 (12) :3069-3074

[3] Comparisons between different polychemotherapy regimens for early breast cancer: meta-analyses of long-term outcome among 100 000 women in 123 randomised trials [J].

Albain, K. ;

Anderson, S. ;

Arriagada, R. ;

Barlow, W. ;

Bergh, J. ;

Bliss, J. ;

Buyse, M. ;

Cameron, D. ;

Carrasco, E. ;

Clarke, M. ;

Correa, C. ;

Coates, A. ;

Collins, R. ;

Costantino, J. ;

Cutter, D. ;

Cuzick, J. ;

Darby, S. ;

Davidson, N. ;

Davies, C. ;

Davies, K. ;

Delmestri, A. ;

Di Leo, A. ;

Dowsett, M. ;

Elphinstone, P. ;

Evans, V. ;

Ewertz, M. ;

Gelber, R. ;

Gettins, L. ;

Geyer, C. ;

Goldhirsch, A. ;

Godwin, J. ;

Gray, R. ;

Gregory, C. ;

Hayes, D. ;

Hill, C. ;

Ingle, J. ;

Jakesz, R. ;

James, S. ;

Kaufmann, M. ;

Kerr, A. ;

MacKinnon, E. ;

McGale, P. ;

McHugh, T. ;

Norton, L. ;

Ohashi, Y. ;

Paik, S. ;

Pan, H. C. ;

Perez, E. ;

Peto, R. ;

Piccart, M. .

LANCET, 2012, 379 (9814) :432-444

[4] Prognostic and predictive value of the 21-gene recurrence score assay in postmenopausal women with node-positive, oestrogen-receptor-positive breast cancer on chemotherapy: a retrospective analysis of a randomised trial [J].

Albain, Kathy S. ;

Barlow, William E. ;

Shak, Steven ;

Hortobagyi, Gabriel N. ;

Livingston, Robert B. ;

Yeh, I-Tien ;

Ravdin, Peter ;

Bugarini, Roberto ;

Boehner, Frederick L. ;

Davidson, Nancy E. ;

Sledge, George W. ;

Winer, Eric P. ;

Hudis, Clifford ;

Ingle, James N. ;

Perez, Edith A. ;

Pritchard, Kathleen I. ;

Shepherd, Lois ;

Gralow, Julie R. ;

Yoshizawa, Carl ;

Allred, D. Craig ;

Osborne, C. Kent ;

Hayes, Daniel F. .

LANCET ONCOLOGY, 2010, 11 (01) :55-65

[5]

[Anonymous], SEOM CIFRAS CANC ESP

[6]

[Anonymous], 2010, T M AM SURG ASS

[7]

[Anonymous], 2015, CANCER RES

[8]

[Anonymous], 2013, J CLIN ONCOL, V31, P5, DOI [10.1200/jco.2013.31.18_suppl.5, 10.1200/jco.2013.31.18suppl.5]

[9] Surgical guidelines for the management of breast cancer Association of Breast Surgery at BASO 2009 [J].

不详 .

EJSO, 2009, 35 :S1-S22

[10] Recommendations for the follow-up care of female breast cancer survivors: a guideline of the Spanish Society of Medical Oncology (SEOM), Spanish Society of General Medicine (SEMERGEN), Spanish Society for Family and Community Medicine (SEMFYC), Spanish Society for General and Family Physicians (SEMG), Spanish Society of Obstetrics and Gynecology (SEGO), Spanish Society of Radiation Oncology (SEOR), Spanish Society of Senology and Breast Pathology (SESPM), and Spanish Society of Cardiology (SEC) [J].

Barnadas, A. ;

Algara, M. ;

Cordoba, O. ;

Casas, A. ;

Gonzalez, M. ;

Marzo, M. ;

Montero, A. ;

Munoz, M. ;

Ruiz, A. ;

Santolaya, F. ;

Fernandez, T. .

CLINICAL & TRANSLATIONAL ONCOLOGY, 2018, 20 (06) :687-694

← 1 2 3 4 5 6 7 8 9 →